A lumpectomy is used to treat early-stage breast cancer, which includes stage 0, stage I, and stage II. These stages cover cancers that are confined to the breast or have spread only to nearby lymph nodes. The tumor also generally needs to be smaller than 5 centimeters (about 2 inches) and small relative to the overall size of the breast.
Stages That Qualify for a Lumpectomy
Stage 0 breast cancer, also called DCIS (ductal carcinoma in situ), is the earliest form. The abnormal cells are contained within the milk ducts and haven’t spread into surrounding tissue. Lumpectomy is a standard treatment option at this stage, and radiation therapy typically follows to reduce the chance of recurrence. Even with this noninvasive cancer, long-term follow-up matters. One study tracking patients for nearly 13 years found an 8% local recurrence rate after lumpectomy for DCIS, though older research has reported rates as high as 30%.
Stage I cancers are small tumors (up to 2 centimeters) that may have tiny deposits in nearby lymph nodes. Stage II includes slightly larger tumors, up to 5 centimeters, or cancers that have spread to a small number of lymph nodes under the arm. Both stages are strong candidates for lumpectomy as long as the tumor is small enough relative to the breast to leave a good cosmetic result after surgery.
Stage III and stage IV breast cancers are generally not treated with lumpectomy as a first step. At these stages, the cancer is either locally advanced (involving the chest wall or skin) or has spread to distant parts of the body. Some people with larger or more advanced tumors receive chemotherapy first to shrink the cancer, which can sometimes make lumpectomy possible afterward, but that’s decided on a case-by-case basis.
What Makes Someone a Good Candidate
Stage alone doesn’t determine whether a lumpectomy will work. The tumor needs to be in a single area of the breast. If there are multiple separate clusters of cancer cells in different parts of the breast, a mastectomy is more likely to be recommended. The ratio of tumor size to breast size also matters. A 4-centimeter tumor in a very small breast may not leave enough healthy tissue for an acceptable result, while the same tumor in a larger breast could be straightforward to remove.
Surgeons aim for what’s called a “negative margin,” meaning no cancer cells are found at the very edge of the removed tissue. For invasive breast cancer, the standard is “no ink on tumor,” meaning cancer cells don’t touch the inked outer edge of the specimen. For DCIS, guidelines call for at least a 2-millimeter margin of clear tissue. If the margins aren’t clear on the first attempt, a second surgery may be needed. Re-excision rates for DCIS have been reported around 30%.
Lymph Node Testing During Surgery
During a lumpectomy for invasive breast cancer, surgeons typically perform a sentinel lymph node biopsy at the same time. This involves removing one to three lymph nodes closest to the tumor to check whether cancer has spread beyond the breast. If those nodes are clear, no further lymph node removal is needed.
Research from the National Cancer Institute has shown that for women with stage I or II cancer who have cancer in only one or two sentinel nodes, removing additional lymph nodes doesn’t improve survival. This means many women with limited lymph node involvement can still have a lumpectomy without extensive surgery under the arm, which reduces the risk of side effects like chronic arm swelling.
Lumpectomy Plus Radiation vs. Mastectomy
For early-stage breast cancer, survival rates are identical whether you choose a lumpectomy with radiation or a full mastectomy. A large analysis by the Early Breast Cancer Trialists’ Collaborative Group found that 10-year overall survival was 71% for both approaches, with no statistically significant difference between groups. The choice between the two comes down to factors like tumor location, breast size, personal preference, and whether radiation is feasible.
What Happens After Surgery
Radiation therapy is a standard part of treatment after a lumpectomy. It targets any microscopic cancer cells that may remain in the breast tissue and significantly reduces the risk of the cancer returning in the same breast. The traditional schedule has been daily treatments, five days a week, for five to six weeks. Shorter courses are increasingly common. Whole-breast radiation can often be completed in one to four weeks, and partial-breast radiation (targeting only the area around the tumor site) may take five days or fewer.
Depending on the cancer’s specific characteristics, your treatment plan may also include hormone therapy, chemotherapy, or targeted therapy after surgery. These decisions are based on factors like hormone receptor status, tumor grade, and whether cancer was found in the lymph nodes, not simply on the stage at diagnosis.